Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Salvianolate Injection in Elderly Patients With Unstable Angina Pectoris
ChiCTR-IPR-17010481Phase 4Recruiting
- Sponsor
- Chinese PLA General Hospital
- Start
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of salvianolate in unstable angina (2 arms), sponsored by Chinese PLA General Hospital. Primary endpoint: symptom of angina pectoris. Started May 2016; status: recruiting.
02
Drugs
salvianolate
03
Conditions
unstable angina
Beyond the preview
Go deeper on ChiCTR-IPR-17010481.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17010481.